peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events
TB-500 (the fragment) has a substantial preclinical evidence base, though it's somewhat smaller than BPC-157's
Rather than being outcomes themselves, the peptides may be used to probe: How cells move and organize (often discussed with TB4-related actin dynamics)
The Beauty & Regeneration Peptide Support healthy skin, fuller-looking hair, and graceful aging with GHK-Cu, a naturally occurring copper peptide recognized for its regenerative and beauty-supporting properties
0.01%, a 150x difference), or specific product strengths like credit cards and fraud protection
The good news is you can address most of these issues
